BioAscent is pleased to be attending Discovery & Development Europe 2026, on the ELRIG track 'Target Innovation & Novel Screening Technologies' - part of Oxford Global's Drug Discovery Europe 2026 conference.

The event will be held in Berlin on 15 June.

The event will bring together industry colleagues to view showcase strategies, breakthrough science, and cutting-edge technologies in target discovery, medicinal chemistry, and drug design.

The BioAscent team will be available to meet fellow delegates during the symposium. If you’d like to arrange a meeting, please get in touch by emailing info@bioascent.com.

Find out more about the event here.